Records containing: Recurrent Intraocular Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2024-03-04Phase II Study of gp100:209-217 (210M) Antigen and MART-1:26-35 (27L) Antigen Emulsified in Montanide ISA-51 in Patients With Metastatic Ocular Melanoma
-
CLINICAL_TRIALS study record update · 2018-10-29Adjuvant Therapy for Patients With Primary Uveal Melanoma With Genetic Imbalance
-
CLINICAL_TRIALS study record update · 2018-05-09Predictive Markers of Response in a Phase II Trial of Axitinib in Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2016-03-10Pilot Study of Sequential Hepatic Radioembolization and Systemic Ipilimumab in Patients With Uveal Melanoma Metastatic to Liver
-
CLINICAL_TRIALS study record update · 2015-07-20Phase II Study of IMC-A12 in Metastatic Uveal Melanoma
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-02-04A Phase 2 Study Evaluating the Efficacy of VEGF Trap in Patients With Recurrent Inoperable Stage III or Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2014-10-03A Phase II Study of Vorinostat in Patients With Advanced Melanoma
-
CLINICAL_TRIALS study record update · 2014-05-22A PHASE II TRIAL OF A VACCINE COMBINING MULTIPLE CLASS I PEPTIDES WITH MONTANIDE ISA 51 OR ISA 51 VG AND CpG ADJUVANT 7909 FOR PATIENTS WITH RESECTED STAGES IIC/III AND IV MELANOMA
-
CLINICAL_TRIALS study record update · 2013-03-05A Phase II Trial of PS-341 in Combination With Paclitaxel and Carboplatin for the Treatment of Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-07-11Phase II Trial of BAY 43-9006 (Sorafenib; NSC-724772) in Combination With Carboplatin and Paclitaxel in Patients With Metastatic Uveal Melanoma